Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 8/20 | 0.32 |
| ▸ | PPARA | Q07869 | 8/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.30 |
| ▸ | CHRNG | P07510 | 2/20 | 0.30 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26002104 | 1.00 | CA12 (0.35) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002088 | 1.00 | CA12 (0.35) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002241 | 1.00 | CA12 (0.35) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002193 | 0.97 | CA12 (0.37) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002200 | 0.97 | CA12 (0.37) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002192 | 0.97 | CA12 (0.37) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002210 | 0.97 | CA12 (0.37) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26001855 | 0.95 | CA12 (0.36) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL18371319 | 0.95 | CA12 (0.38) | CA12CA1CA2CA9CHRNB4 | |
| SCHEMBL26002126 | 0.95 | CA12 (0.37) | CA12CA1CA2CA9CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230262999-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | CA12 1567/4885CA1 1766/4885CA2 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.